COMMUNIQUÉS West-GlobeNewswire

Frederick Breathe Free Celebrates Dr. Jamie Oberman’s Recognition as a 2026 Castle Connolly Top Doctor
05/10/2026
Dr. Oberman’s recognition highlights his commitment to thoughtful, patient-centered ENT care at Frederick Breathe Free. Frederick, MD, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Frederick Breathe Free Sinus & Allergy Centers [...]
Zealand Pharma – Completion of share buy-back program and related transactions (week 40 and 41, 2026)
05/10/2026
Company announcement No. 53 / 2026 Zealand Pharma - Completion of share buy-back program and related transactions (week 40 and 41, 2026) Copenhagen, Denmark, October 5, 2026 – Zealand Pharma A/S ("the Company" or “ [...]
Global Alzheimer's Platform Foundation Names New Medical Director at Tampa Research Site
05/10/2026
WASHINGTON, D. C. , Oct. 05, 2026 (GLOBE NEWSWIRE) -- The Global Alzheimer's Platform Foundation ® (GAP), announced today that Dr. Jeffery Greenberg is joining GAP as the Medical Director and Principal Investigator of [...]
Declaration of shares and voting rights - Status as of September 30, 2026
05/10/2026
VALNEVA Declaration of shares and voting rights Status as of September 30, 2026 __________________________________________________________________________________________ Company name: VALNEVA Registered office: Îlot [...]
Déclaration d’actions et de droits de vote - Statut au 30 septembre 2026
05/10/2026
VALNEVA Déclaration d’actions et de droits de vote Statut au 30 septembre 2026 __________________________________________________________________________________________ Dénomination sociale : VALNEVA Adresse du siège [...]
Efficacy of aprocitentan in patients across the cardiometabolic disease spectrum including obesity to be presented at AHA Hypertension
05/10/2026
Two oral presentations at AHA Hypertension 2026 will highlight the substantial antihypertensive efficacy of aprocitentan in two hypertension populations from the PRECISION study: patients with obesity and patients [...]
Sironax Named to Fierce Biotech’s “Fierce 15” List of the Most Innovative and Promising Private Biotechs of 2026
05/10/2026
Recognized for bold approach to addressing therapeutic targets WALTHAM, Mass., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Sironax, a global clinical-stage biotechnology company developing transformative therapies for [...]
Ostia Sciences Publishes Second International Patent Application Covering the Sorbitol Switch That Drives Production of Phosphorylated Lantibiotics
05/10/2026
WO 2026/178627 covers methods, uses and compositions pairing Streptococcus salivarius SALI-10 with sorbitol, creating a synbiotic system designed to support the strain and increase production of its phosphorylated [...]
Medicovestor Announces FDA IND Clearance for MC001, Advancing to An International Phase 1 Study
05/10/2026
NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Medicovestor, Inc. today announced FDA clearance of its Investigational New Drug (IND) application for MC001, the Company's first-in-class dimeric chemoimmunotherapy ADC for [...]
Assembly Biosciences to Present Positive Phase 1a Safety, Tolerability and Target Engagement Data for ABI-6250 at AASLD The Liver Meeting® 2026
05/10/2026
– ABI-6250's pharmacodynamic analysis was recognized as a Poster of Distinction – SOUTH SAN FRANCISCO, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company [...]
Research Peptide Companies: Kylo Peptides Scores 96.7/100 in Plastic Surgery Key Review
05/10/2026
Sheridan, Wyoming, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Kylo Peptides https://kylopeptides.com/ [], a U.S.-based supplier of research-use-only peptides, has received a score of 96.7/100 in a Plastic Surgery Key review of [...]
Transactions under Novonesis’ share buyback program
05/10/2026
Please read the announcement in PDF Attachment 2026_20_Share_buyback
Alpha Tau to Participate in October Investor Conferences
05/10/2026
JERUSALEM, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT ® , today announced [...]
Human Appeal Celebrates Top UK Volunteers at Third Annual Purple Legacy Awards
05/10/2026
MANCHESTER, United Kingdom, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Leading Humanitarian charity Human Appeal brought together 150 volunteers, staff and guests from London, the Midlands, the North and Scotland in Manchester [...]
AIM ImmunoTech Highlights Recent Media Coverage of Ampligen’s® Broad-Spectrum Antiviral and Biodefense Potential
05/10/2026
OCALA, Fla., Oct. 05, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today highlighted recent media coverage of the antiviral potential of Ampligen ® (rintatolimod), the [...]
Beacon Therapeutics Named a “Fierce 15” Company by Fierce Biotech
05/10/2026
LONDON and CAMBRIDGE, Mass., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Beacon Therapeutics, a leading clinical-stage biotechnology company with a mission to save and restore vision in people with rare and prevalent ocular [...]
Curia Invests $28 Million in Sterile API Manufacturing
05/10/2026
ALBANY, N.Y., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading global contract, development and manufacturing organization (CDMO), today announced a strategic investment to expand its sterile API [...]
Curia investit 28 millions de dollars dans la fabrication d’API stériles
05/10/2026
ALBANY, N.Y., 05 oct. 2026 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), une organisation mondiale de premier plan spécialisée dans le développement et de fabrication sous contrat (CDMO), a annoncé aujourd’hui un [...]
Pistol and Paris Launches Vanquish Medical Providing Access and Serving Medical Cannabis Patients Across Canada
05/10/2026
Vanquish Medical Platform Provides a Portfolio of Pistol and Paris Products, Patient Support, Direct Billing and Speciality Services for Cannabis Patients AGASSIZ, B.C., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Vanquish [...]

Pages